Outlook Therapeutics Inc
F:41ON
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Outlook Therapeutics Inc
F:41ON
|
US |
|
N
|
Nippon Steel Corp
XMUN:NPS
|
JP |
|
Amper SA
MAD:AMP
|
ES |
|
C
|
City Developments Ltd
OTC:CDEVY
|
SG |
|
Leoni AG
F:LEO
|
DE |
|
S
|
Smartone Telecommunications Holdings Ltd
F:SMA
|
HK |
|
C
|
Cohen & Steers Inc
F:FG9
|
US |
|
A
|
Ashoka Buildcon Ltd
BSE:533271
|
IN |
Intrinsic Value
The intrinsic value for
Outlook Therapeutics Inc (41ON) under the Base Case is hidden
EUR.
Compared with the current market price of 1.537 EUR, the stock appears hidden
.
Do our valuations actually work? See backtest results .
41ON looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether 41ON usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Outlook Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Outlook Therapeutics Inc
Earnings Waterfall
Outlook Therapeutics Inc
The intrinsic value for
Outlook Therapeutics Inc (41ON) under the Base Case is hidden EUR.
Compared with the current market price of 1.537 EUR, the stock appears hidden.